Hyperalphalipoproteinemia

MONDO:0015903

An autosomal dominant genetic condition caused by mutation(s) in the CETP gene, encoding cholesteryl ester transfer protein. Affected individuals may have increased longevity due to decreased risk of coronary heart disease.

Also known as: HALP1

1 clinical trial for this condition and its sub-types, 0 tagged with Hyperalphalipoproteinemia itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Hyperlipidemia (400) ↑ Hyperlipoproteinemia (106)

Sub-types of Hyperalphalipoproteinemia

Cholesterol-ester transfer protein deficiency 0 trials
Hyperlipidemia due to hepatic triglyceride lipase deficiency 0 trials

Including sub-types (1) Tagged with Hyperalphalipoproteinemia (0)

We haven't found any trials for this condition yet. Follow it to get notified when new trials appear.